Samuel Philip Rowbotham, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hedgehog Proteins | 1 | 2022 | 768 | 0.570 |
Why?
|
| Histone Demethylases | 1 | 2018 | 323 | 0.510 |
Why?
|
| Lung Neoplasms | 5 | 2022 | 13381 | 0.380 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2020 | 1745 | 0.380 |
Why?
|
| Chromatin | 4 | 2023 | 2961 | 0.360 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3801 | 0.350 |
Why?
|
| DNA Helicases | 3 | 2015 | 851 | 0.350 |
Why?
|
| Lung | 4 | 2023 | 10002 | 0.320 |
Why?
|
| Cell Lineage | 1 | 2017 | 2557 | 0.300 |
Why?
|
| DNA Replication | 2 | 2011 | 1418 | 0.290 |
Why?
|
| Methylation | 2 | 2023 | 1084 | 0.260 |
Why?
|
| Stem Cells | 1 | 2017 | 3524 | 0.230 |
Why?
|
| Organoids | 2 | 2020 | 746 | 0.220 |
Why?
|
| Disease Progression | 1 | 2018 | 13510 | 0.190 |
Why?
|
| Histones | 2 | 2011 | 2580 | 0.190 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2018 | 682 | 0.180 |
Why?
|
| Heterochromatin | 2 | 2011 | 293 | 0.160 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6345 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 1974 | 0.130 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2015 | 94 | 0.120 |
Why?
|
| Genes, erbB-1 | 1 | 2015 | 162 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1351 | 0.110 |
Why?
|
| Acetylation | 2 | 2011 | 1055 | 0.100 |
Why?
|
| Animals | 8 | 2023 | 168475 | 0.100 |
Why?
|
| Mice | 6 | 2023 | 81539 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1726 | 0.090 |
Why?
|
| Histone Deacetylase 1 | 1 | 2011 | 133 | 0.090 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 283 | 0.090 |
Why?
|
| S Phase | 1 | 2011 | 421 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 670 | 0.080 |
Why?
|
| Mutation | 1 | 2014 | 30053 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1860 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5791 | 0.080 |
Why?
|
| Nucleosomes | 1 | 2011 | 488 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1171 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 836 | 0.070 |
Why?
|
| Wound Healing | 1 | 2017 | 2805 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2011 | 3094 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2014 | 2448 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2015 | 12130 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 16990 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4576 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2011 | 5035 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2898 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4915 | 0.050 |
Why?
|
| RNA Interference | 1 | 2011 | 2832 | 0.050 |
Why?
|
| DNA Repair | 1 | 2011 | 2046 | 0.050 |
Why?
|
| Cell Movement | 1 | 2014 | 5205 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4281 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18255 | 0.050 |
Why?
|
| Phenotype | 1 | 2018 | 16592 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5799 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2022 | 23447 | 0.040 |
Why?
|
| Protein Binding | 1 | 2011 | 9353 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5821 | 0.040 |
Why?
|
| Cell Line | 1 | 2011 | 15601 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2011 | 18966 | 0.030 |
Why?
|
| Anaphase | 1 | 2015 | 114 | 0.030 |
Why?
|
| Etoposide | 1 | 2015 | 634 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11904 | 0.030 |
Why?
|
| Humans | 7 | 2022 | 761596 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2014 | 305 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 621 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1612 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 616 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 634 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3848 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 2932 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3605 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3597 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 1989 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 1509 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3449 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9490 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5314 | 0.010 |
Why?
|